chrX-132628419-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001394073.1(HS6ST2):c.1742C>T(p.Pro581Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000665 in 1,202,292 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001394073.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS6ST2 | NM_001394073.1 | c.1742C>T | p.Pro581Leu | missense_variant | 5/5 | ENST00000370833.7 | NP_001381002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS6ST2 | ENST00000370833.7 | c.1742C>T | p.Pro581Leu | missense_variant | 5/5 | 5 | NM_001394073.1 | ENSP00000359870 |
Frequencies
GnomAD3 genomes AF: 0.00000902 AC: 1AN: 110904Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33130
GnomAD4 exome AF: 0.00000641 AC: 7AN: 1091388Hom.: 0 Cov.: 29 AF XY: 0.00000559 AC XY: 2AN XY: 357534
GnomAD4 genome AF: 0.00000902 AC: 1AN: 110904Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33130
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 12, 2022 | Variant summary: HS6ST2 c.1742C>T (p.Pro581Leu) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 172563 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1742C>T in individuals affected with Paganini-Miozzo Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Jul 11, 2023 | PM2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at